Myovant Sciences Ltd

(NYSE:MYOV)

Latest On Myovant Sciences Ltd (MYOV):

Date/Time Type Description Signal Details
2023-01-26 23:06 ESTNewsMyovant Sciences GAAP EPS of -$0.56 beats by $0.08, revenue of $100.23M misses by $2.13MN/A
2022-10-26 20:33 ESTNewsMyovant Sciences GAAP EPS of -$0.47 beats by $0.02, revenue of $104.8M beats by $11.33MN/A
2022-10-26 04:27 ESTNewsMyovant Sciences Q2 2023 Earnings PreviewN/A
2022-10-25 14:19 ESTNewsNot The Buyout Offer That Myovant Shareholders Hoped ForN/A
2022-10-25 00:36 ESTNewsMyovant Sciences cancels Q2 earnings call in light of Sumitovant acquisitionN/A
2022-10-24 10:24 ESTNewsMyovant stock pops as Sumitovant to acquire remaining stake for $1.7BN/A
2022-10-07 19:08 ESTNewsMyovant Sciences: What The Sumitomo Offer ForetellsN/A
2022-10-04 19:16 ESTNewsMyovant Sciences hits 52-week high as observers see higher takeover offerN/A
2022-10-04 19:16 ESTNewsMyovant: Sumitomo Bid Is A Head Scratcher, Where Is The Value?N/A
2022-10-04 04:23 ESTNewsHot Stocks: Oil stocks surge; VSAT, MYOV climb on M&A headlines; APRN drops almost 50%N/A
2022-10-03 14:12 ESTNewsMyovant climbs 32% after rejection of $2.4B buyout offerN/A
2022-10-03 14:12 ESTNewsMyovant Sciences trades above $22.75/share as analysts see likely higher bidN/A
2022-10-03 00:34 ESTNewsMyovant Sciences rejects Sumitovant Biopharma's $2.4 billion takeover offerN/A
2022-09-20 19:48 ESTNewsMyovant: Overvalued Despite Compelling Results From MYFEMBREEN/A
2022-08-30 07:41 ESTNewsMyovant Sciences: Regulatory Overhang ClearedN/A
2022-08-10 03:30 ESTNewsMyovant Sciences upgraded to outperform at SVB following additional Myfembree indicationN/A
2022-08-09 05:39 ESTNewsHot Stocks: DINO gains on Q2 results, MYOV rises on FDA news, BNTX sinks on earnings, and PLTR drops 14%N/A
2022-08-06 12:36 ESTNewsMyovant, Pfizer win approval of Myfembree for pain associated with endometriosisN/A
2022-07-27 22:02 ESTNewsMyovant Sciences GAAP EPS of -$0.22 beats by $0.10, revenue of $116.49M beats by $25.19MN/A
2022-07-27 22:02 ESTNewsMyovant stock gains ~6% after hours on Q1 revenue jumpN/A
2022-07-27 22:01 ESTNewsMyovant Sciences Ltd. (MYOV) CEO Dave Marek on Q1 2022 Results - Earnings Call TranscriptN/A
2022-07-26 19:04 ESTNewsMyovant Sciences Q1 2023 Earnings PreviewN/A
2022-07-22 19:54 ESTNewsMyovant: Earnings And Approval Catalysts In Play But Valuation Looks ExcessiveN/A
2022-07-18 15:37 ESTNewsMyovant Makes Commercial Progress As It Waits For FDA Decision On MyfembreeN/A
2022-06-02 12:12 ESTNewsU.S. FDA accepts Myovant, Pfizer application seeking expanded approval for MyfembreeN/A
2022-05-11 06:48 ESTNewsMyovant Sciences Ltd. 2021 Q4 - Results - Earnings Call PresentationN/A
2022-05-11 06:48 ESTNewsMyovant stock rises 25% as Q4 revenue soars Y/Y, partner Pfizer to buy BiohavenN/A
2022-05-11 06:48 ESTNewsMyovant Sciences Ltd. (MYOV) CEO Dave Marek on Q4 2021 Results - Earnings Call TranscriptN/A
2022-05-10 10:35 ESTNewsMyovant Sciences GAAP EPS of -$0.63 misses by $0.09, revenue of $57.6M misses by $14.74MN/A
2022-05-09 13:53 ESTNewsMyovant in pact with Accord Healthcare to commercialize Orgovyx in EuropeN/A
2022-05-09 13:52 ESTNewsMyovant Sciences FQ4 2022 Earnings PreviewN/A
2022-05-07 05:16 ESTNewsFDA review for label expansion of Pfizer, Myovant uterine fibroids therapy extendedN/A
2022-04-26 15:55 ESTNewsMyovant: Poised To Overcome Regulatory IssuesN/A
2022-04-15 16:18 ESTNewsMyovant: Endometriosis Setback Hints At Deeper Issues Around Pfizer PartnershipN/A
2022-04-13 20:30 ESTNewsRegulatory Setback Brings Myovant Sciences Stock To Attractive LevelsN/A
2022-04-13 05:39 ESTNewsHot Stocks: Coal stocks rise; GNS jumps 400% in debut; HSY sets high; WULF, MYOV plungeN/A
2022-04-12 15:02 ESTNewsPfizer, Myovant face regulatory issues in Myfembree label expansionN/A
2022-03-26 06:04 ESTNewsMyovant: Approved Drugs And Upcoming Catalysts Make This A Great Long-Term PlayN/A
2022-02-25 11:44 ESTNewsMyovant secures European recommendation for prostate cancer therapyN/A
2022-01-27 01:04 ESTNewsMyovant Sciences Ltd. (MYOV) CEO Dave Marek on Q3 2021 Results - Earnings Call TranscriptN/A
2022-01-26 08:35 ESTNewsMyovant Sciences GAAP EPS of -$0.68 misses by $0.07, revenue of $54.4M in-lineN/A
2022-01-25 16:14 ESTNewsMyovant Sciences Q3 2021 Earnings PreviewN/A
2022-01-10 23:07 ESTNewsMyovant Sciences FQ3 prelim revenues seen growing significantlyN/A
2022-01-03 07:11 ESTNewsMyovant: Catalysts Powering More UpsideN/A
2021-11-16 04:59 ESTNewsReview Of Myovant Sciences And A Consideration Of Steps Following Commercial LaunchN/A
2021-11-15 09:13 ESTNewsReview Myovant Sciences And A Consideration Of Steps Following Commercial LaunchN/A
2021-10-26 23:38 ESTNewsMyovant Sciences EPS beats by $0.15, beats on revenueN/A
2021-10-26 23:37 ESTNewsMyovant Sciences nears a three-month low after setback for partnership with PfizerN/A
2021-10-26 23:37 ESTNewsMyovant Sciences Ltd. (MYOV) CEO Dave Marek on Q2 2021 Results - Earnings Call TranscriptN/A
2021-10-25 22:12 ESTNewsMyovant Sciences FQ2 2022 Earnings PreviewN/A

About Myovant Sciences Ltd (MYOV):

Myovant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for women's health and endocrine diseases. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antagonist for the treatment of heavy menstrual bleeding related with uterine fibroids, endometriosis-associated pain, and advanced prostate cancer. It is also developing MVT-602, an oligopeptide kisspeptin agonist, for the treatment of female infertility as part of assisted reproduction. Myovant Sciences Ltd. has collaboration with Pfizer Inc. to develop and commercialize relugolix in oncology and women's health. The company was formerly known as Roivant Endocrinology Ltd. and changed its name to Myovant Sciences Ltd. in May 2016. The company was founded in 2016 and is based in London, the United Kingdom. As of December 27, 2019, Myovant Sciences Ltd. operates as a subsidiary of Sumitovant Biopharma Ltd.

MYOV Quotes by TradingView

See Advanced Chart

General

  • Name Myovant Sciences Ltd
  • Symbol MYOV
  • Type Common Stock
  • Exchange NYSE
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 214
  • Fiscal Year EndMarch
  • IPO Date2016-10-27
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://myovant.com
View More

Valuation

  • Price/Sales (Trailing 12 Mt.) 63.73
  • Price/Book (Most Recent Quarter) 70.01
  • Enterprise Value Revenue 49.32
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$2.66
  • Next Year EPS Estimate -$1.56
  • Next Quarter EPS Estimate -$0.84
  • Operating Margin -714%
  • Return on Assets -34%
  • Revenue 34.71 million
  • Earnings Per Share -$3.98
  • Revenue Per Share $0.39
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 2.29 billion
  • EBITDA -269308992
  • Analyst Target Price $37.5
  • Book Value Per Share $0.19
View More

Share Statistics

  • Shares Outstanding 90.8 million
  • Shares Float 36.26 million
  • % Held by Insiders 5998%
  • % Held by Institutions 34.77%
  • Shares Short 4.02 million
  • Shares Short Prior Month 2.71 million
  • Short Ratio 4.15
  • Short % of Float 10%
  • Short % of Shares Outstanding 4%
View More

Technicals

  • Beta 2.99
  • 52 Week High $29.71
  • 52 Week Low $7.12
  • 50 Day Moving Average 23.09
  • 200 Day Moving Average 20.87
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Myovant Sciences Ltd (MYOV) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Myovant Sciences Ltd (MYOV) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-11$1.38 million-$0.82-$0.886.31%
2020-09-302020-11-12$N/A-$0.75-$0.761.19%
2020-06-302020-08-11$N/A-$0.37-$0.6038.33%
2020-03-312020-05-18$N/A-$0.73-$0.71-2.8%
2019-12-312020-02-10$N/A-$0.91-$0.78-16.9%
2019-09-302019-11-12$N/A-$0.79-$0.74-6.93%
2019-06-302019-08-06$N/A-$0.89-$0.999.67%
2019-03-312019-05-24$N/A-$1.07-$1.03-3.89%
2018-12-312019-02-07$N/A-$1.04-$0.97-6.69%
2018-09-302018-11-08$N/A-$0.99-$0.97-2.23%
2018-06-302018-08-07$N/A-$0.98-$0.81-21.74%
2018-03-312018-06-07$N/A-$0.81-$0.78-4.06%
2017-12-312018-02-13$N/A-$0.70-$0.48-46.84%
2017-09-302017-11-13$N/A-$0.50-$0.38-30.45%
2017-06-302017-08-10$N/A-$0.39-$0.29-34.48%
2017-03-312017-06-14$N/A-$0.36-$0.18-100%
2016-12-312017-02-13$N/A-$0.15-$0.2641.57%
2016-09-302016-11-21$N/A-$0.45-$0.35-29.8%

Myovant Sciences Ltd (MYOV) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Myovant Sciences Ltd (MYOV) Chart:

Myovant Sciences Ltd (MYOV) News:

Below you will find a list of latest news for Myovant Sciences Ltd (MYOV) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Myovant Sciences Ltd (MYOV) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent

Latest MYOV Trades:

Date Shares Price
Jun 13, 2022 7:58 PM EST18$10.335
Jun 13, 2022 7:59 PM EST100$10.34
Jun 13, 2022 7:59 PM EST100$10.35
Jun 13, 2022 7:59 PM EST3$10.365
Jun 13, 2022 7:59 PM EST59$10.38

Myovant Sciences Ltd (MYOV) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919120039080/0001209191-20-039080-index.htm
2019-06-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000089924319015895/0000899243-19-015895-index.htm
2019-07-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000089924319019541/0000899243-19-019541-index.htm
2020-01-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000089924320000338/0000899243-20-000338-index.htm
2020-03-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000089924320008835/0000899243-20-008835-index.htm
2020-03-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000089924320009088/0000899243-20-009088-index.htm
2020-03-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000089924320009332/0000899243-20-009332-index.htm
2020-03-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000089924320009469/0000899243-20-009469-index.htm
2020-03-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000089924320009633/0000899243-20-009633-index.htm
2020-04-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000089924320009776/0000899243-20-009776-index.htm
2020-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000089924320010095/0000899243-20-010095-index.htm
2020-04-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000089924320010382/0000899243-20-010382-index.htm
2020-04-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000089924320010563/0000899243-20-010563-index.htm
2020-04-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000089924320010666/0000899243-20-010666-index.htm
2020-04-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000089924320010804/0000899243-20-010804-index.htm
2020-04-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000089924320010899/0000899243-20-010899-index.htm
2020-04-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000089924320011041/0000899243-20-011041-index.htm
2020-04-234Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000089924320011209/0000899243-20-011209-index.htm
2020-04-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000089924320011334/0000899243-20-011334-index.htm
2020-04-294Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000089924320011506/0000899243-20-011506-index.htm
2020-05-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000089924320011728/0000899243-20-011728-index.htm
2020-05-054Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000089924320012040/0000899243-20-012040-index.htm
2020-05-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000089924320012209/0000899243-20-012209-index.htm
2020-05-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000089924320012570/0000899243-20-012570-index.htm
2020-05-114/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000089924320012574/0000899243-20-012574-index.htm
2020-05-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000089924320013027/0000899243-20-013027-index.htm
2020-05-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000089924320013205/0000899243-20-013205-index.htm
2020-05-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000089924320013546/0000899243-20-013546-index.htm
2020-05-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000089924320013825/0000899243-20-013825-index.htm
2019-01-103Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000090342319000013/0000903423-19-000013-index.htm
2019-01-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1679082/000090342319000021/0000903423-19-000021-index.htm
2019-06-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000090342319000244/0000903423-19-000244-index.htm
2019-06-134Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000090342319000245/0000903423-19-000245-index.htm
2019-06-14SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1679082/000090342319000246/0000903423-19-000246-index.htm
2019-07-12SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1679082/000090342319000289/0000903423-19-000289-index.htm
2019-07-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000090342319000294/0000903423-19-000294-index.htm
2019-07-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000090342319000295/0000903423-19-000295-index.htm
2019-06-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000091957419003993/0000919574-19-003993-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1679082/000110465919007912/0001104659-19-007912-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1679082/000110465919007914/0001104659-19-007914-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1679082/000110465919008000/0001104659-19-008000-index.htm
2019-06-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000110465919034348/0001104659-19-034348-index.htm
2019-06-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000110465919034355/0001104659-19-034355-index.htm
2019-06-14SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1679082/000110465919035694/0001104659-19-035694-index.htm
2019-06-14SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1679082/000110465919035706/0001104659-19-035706-index.htm
2019-06-14SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1679082/000110465919035707/0001104659-19-035707-index.htm
2019-07-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000110465919040420/0001104659-19-040420-index.htm
2019-07-154Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000110465919040425/0001104659-19-040425-index.htm
2019-07-16SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1679082/000110465919040588/0001104659-19-040588-index.htm
2019-07-17SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1679082/000110465919040593/0001104659-19-040593-index.htm
2019-07-17SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1679082/000110465919040597/0001104659-19-040597-index.htm
2019-09-06SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1679082/000110465919049113/0001104659-19-049113-index.htm
2019-11-04SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1679082/000110465919059171/0001104659-19-059171-index.htm
2019-11-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000110465919066768/0001104659-19-066768-index.htm
2019-11-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000110465919068249/0001104659-19-068249-index.htm
2019-11-27SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1679082/000110465919068256/0001104659-19-068256-index.htm
2019-12-044Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000110465919069974/0001104659-19-069974-index.htm
2019-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000110465919073807/0001104659-19-073807-index.htm
2019-12-31SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1679082/000110465919077342/0001104659-19-077342-index.htm
2019-12-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000110465919077345/0001104659-19-077345-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1679082/000110465920021911/0001104659-20-021911-index.htm
2019-08-06S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1679082/000114036119014358/0001140361-19-014358-index.htm
2019-08-278-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1679082/000114036119015663/0001140361-19-015663-index.htm
2019-10-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1679082/000114036119019474/0001140361-19-019474-index.htm
2019-12-23PRE 14COther preliminary information statementshttps://www.sec.gov/Archives/edgar/data/1679082/000114036119023095/0001140361-19-023095-index.htm
2019-12-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1679082/000114036119023390/0001140361-19-023390-index.htm
2020-01-03DEF 14COther definitive information statementshttps://www.sec.gov/Archives/edgar/data/1679082/000114036120000103/0001140361-20-000103-index.htm
2020-05-088-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1679082/000114036120011048/0001140361-20-011048-index.htm
2020-05-15POSASRPost-effective Amendment to an automatic shelf registration statementhttps://www.sec.gov/Archives/edgar/data/1679082/000114036120011682/0001140361-20-011682-index.htm
2020-05-18S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1679082/000114036120011876/0001140361-20-011876-index.htm
2020-05-19POS AMPost-Effective amendments for registration statementhttps://www.sec.gov/Archives/edgar/data/1679082/000114036120011896/0001140361-20-011896-index.htm
2020-07-24DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1679082/000114036120016652/0001140361-20-016652-index.htm
2020-07-24DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1679082/000114036120016656/0001140361-20-016656-index.htm
2020-09-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1679082/000114036120020727/0001140361-20-020727-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1679082/000114420419007585/0001144204-19-007585-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1679082/000114420419008308/0001144204-19-008308-index.htm
2019-06-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000114420419030140/0001144204-19-030140-index.htm
2019-06-14SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1679082/000114420419031037/0001144204-19-031037-index.htm
2019-07-12SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1679082/000114420419034589/0001144204-19-034589-index.htm
2019-07-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000114420419034596/0001144204-19-034596-index.htm
2018-12-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1679082/000119312518362279/0001193125-18-362279-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1679082/000119312519037843/0001193125-19-037843-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1679082/000119312519040158/0001193125-19-040158-index.htm
2019-05-148-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1679082/000119312519146080/0001193125-19-146080-index.htm
2019-05-24PRE 14COther preliminary information statementshttps://www.sec.gov/Archives/edgar/data/1679082/000119312519157128/0001193125-19-157128-index.htm
2019-05-24S-3ASRAutomatic shelf registration statement of securities of well-known seasoned issuershttps://www.sec.gov/Archives/edgar/data/1679082/000119312519157179/0001193125-19-157179-index.htm
2019-05-29424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1679082/000119312519159671/0001193125-19-159671-index.htm
2019-05-31424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1679082/000119312519162988/0001193125-19-162988-index.htm
2019-05-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1679082/000119312519162997/0001193125-19-162997-index.htm
2019-06-048-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1679082/000119312519165035/0001193125-19-165035-index.htm
2019-06-04DEF 14COther definitive information statementshttps://www.sec.gov/Archives/edgar/data/1679082/000119312519165064/0001193125-19-165064-index.htm
2019-06-05SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1679082/000119312519166146/0001193125-19-166146-index.htm
2019-06-14SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1679082/000119312519173840/0001193125-19-173840-index.htm
2019-07-12SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1679082/000119312519193236/0001193125-19-193236-index.htm
2019-07-12SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1679082/000119312519193253/0001193125-19-193253-index.htm
2019-07-25DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1679082/000119312519202512/0001193125-19-202512-index.htm
2020-01-03SC 13DGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1679082/000119312520001517/0001193125-20-001517-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1679082/000119312520037823/0001193125-20-037823-index.htm
2020-03-18SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1679082/000119312520077142/0001193125-20-077142-index.htm
2020-03-26SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1679082/000119312520086486/0001193125-20-086486-index.htm
2020-04-16SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1679082/000119312520108570/0001193125-20-108570-index.htm
2020-05-15SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1679082/000119312520143581/0001193125-20-143581-index.htm
2018-11-083Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919118057785/0001209191-18-057785-index.htm
2018-11-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919118057786/0001209191-18-057786-index.htm
2018-12-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919118060595/0001209191-18-060595-index.htm
2018-12-184Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919118063255/0001209191-18-063255-index.htm
2019-02-204Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919119011541/0001209191-19-011541-index.htm
2019-04-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919119024130/0001209191-19-024130-index.htm
2019-04-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919119024132/0001209191-19-024132-index.htm
2019-04-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919119024135/0001209191-19-024135-index.htm
2019-04-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919119024142/0001209191-19-024142-index.htm
2019-04-094Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919119024148/0001209191-19-024148-index.htm
2019-06-064Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919119035256/0001209191-19-035256-index.htm
2019-06-114Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919119036115/0001209191-19-036115-index.htm
2019-06-144Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919119037137/0001209191-19-037137-index.htm
2019-07-124Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919119041998/0001209191-19-041998-index.htm
2019-08-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919119047528/0001209191-19-047528-index.htm
2019-08-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919119047529/0001209191-19-047529-index.htm
2019-08-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919119047531/0001209191-19-047531-index.htm
2019-08-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919119047533/0001209191-19-047533-index.htm
2019-08-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919119047538/0001209191-19-047538-index.htm
2019-08-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919119047541/0001209191-19-047541-index.htm
2019-08-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919119047542/0001209191-19-047542-index.htm
2019-08-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919119047546/0001209191-19-047546-index.htm
2019-08-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919119047548/0001209191-19-047548-index.htm
2019-12-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919119061300/0001209191-19-061300-index.htm
2019-12-303Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919119062161/0001209191-19-062161-index.htm
2019-12-303Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919119062164/0001209191-19-062164-index.htm
2019-12-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919119062187/0001209191-19-062187-index.htm
2019-12-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919119062189/0001209191-19-062189-index.htm
2020-01-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919120003741/0001209191-20-003741-index.htm
2020-02-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919120012197/0001209191-20-012197-index.htm
2020-03-194Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919120020279/0001209191-20-020279-index.htm
2020-04-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919120023793/0001209191-20-023793-index.htm
2020-04-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919120023794/0001209191-20-023794-index.htm
2020-04-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919120023795/0001209191-20-023795-index.htm
2020-04-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919120023796/0001209191-20-023796-index.htm
2020-04-074Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919120023797/0001209191-20-023797-index.htm
2020-06-244Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919120038726/0001209191-20-038726-index.htm
2020-06-264Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919120039080/0001209191-20-039080-index.htm
2020-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919120047961/0001209191-20-047961-index.htm
2020-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919120047963/0001209191-20-047963-index.htm
2020-08-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919120047968/0001209191-20-047968-index.htm
2020-08-284Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919120048673/0001209191-20-048673-index.htm
2020-08-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919120048799/0001209191-20-048799-index.htm
2020-09-014Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919120048927/0001209191-20-048927-index.htm
2020-09-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919120049162/0001209191-20-049162-index.htm
2020-09-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919120049166/0001209191-20-049166-index.htm
2020-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919120050873/0001209191-20-050873-index.htm
2020-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919120050876/0001209191-20-050876-index.htm
2020-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919120050878/0001209191-20-050878-index.htm
2020-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919120050879/0001209191-20-050879-index.htm
2020-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919120050882/0001209191-20-050882-index.htm
2020-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919120050883/0001209191-20-050883-index.htm
2020-09-174Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1679082/000120919120050887/0001209191-20-050887-index.htm
2020-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1679082/000127417320000096/0001274173-20-000096-index.htm
2020-01-24SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1679082/000139506420000020/0001395064-20-000020-index.htm
2020-01-24SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1679082/000139506420000021/0001395064-20-000021-index.htm
2020-08-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1679082/000156761920014257/0001567619-20-014257-index.htm
2019-02-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1679082/000167908219000008/0001679082-19-000008-index.htm
2019-02-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1679082/000167908219000009/0001679082-19-000009-index.htm
2019-05-248-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1679082/000167908219000017/0001679082-19-000017-index.htm
2019-05-2410-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1679082/000167908219000019/0001679082-19-000019-index.htm
2019-08-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1679082/000167908219000027/0001679082-19-000027-index.htm
2019-08-0610-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1679082/000167908219000030/0001679082-19-000030-index.htm
2019-11-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1679082/000167908219000034/0001679082-19-000034-index.htm
2019-11-1210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1679082/000167908219000036/0001679082-19-000036-index.htm
2020-02-108-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1679082/000167908220000009/0001679082-20-000009-index.htm
2020-02-1010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1679082/000167908220000010/0001679082-20-000010-index.htm
2020-05-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1679082/000167908220000025/0001679082-20-000025-index.htm
2020-05-1810-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1679082/000167908220000026/0001679082-20-000026-index.htm
2020-08-118-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1679082/000167908220000040/0001679082-20-000040-index.htm
2020-08-1110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1679082/000167908220000041/0001679082-20-000041-index.htm
2020-08-06EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1679082/999999999520002049/9999999995-20-002049-index.htm

Myovant Sciences Ltd (MYOV) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Myovant Sciences Ltd (MYOV). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 5998%
Institutional Ownership: 3477%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2019-12-27Sciences Ltd. Roivant10% Share HolderSell45,008,604.000.00https://www.sec.gov/Archives/edgar/data/1679082/000110465919077345/0001104659-19-077345-index.htm
2019-06-12Kathleen SebeliusDirectorBuy100.008.95895.00100.00https://www.sec.gov/Archives/edgar/data/1679082/000120919119037137/0001209191-19-037137-index.htm
2020-04-03Lynn SeelyPrincipal Executive OfficerBuy197,659.001,043,824.00https://www.sec.gov/Archives/edgar/data/1679082/000120919120023797/0001209191-20-023797-index.htm
2020-08-27Ferreira Juan Camilo ArjonaChief Medical OfficerSell7,089.0018.80133,273.20138,026.00https://www.sec.gov/Archives/edgar/data/1679082/000120919120048799/0001209191-20-048799-index.htm
2020-08-28Ferreira Juan Camilo ArjonaChief Medical OfficerSell2,058.0020.0141,180.58138,026.00https://www.sec.gov/Archives/edgar/data/1679082/000120919120048799/0001209191-20-048799-index.htm
2020-08-31Ferreira Juan Camilo ArjonaChief Medical OfficerSell11,307.0020.01226,196.54138,026.00https://www.sec.gov/Archives/edgar/data/1679082/000120919120049162/0001209191-20-049162-index.htm
2020-09-15Ferreira Juan Camilo ArjonaChief Medical OfficerSell100.0022.452,245.00138,026.00https://www.sec.gov/Archives/edgar/data/1679082/000120919120050883/0001209191-20-050883-index.htm
2020-09-15Ferreira Juan Camilo ArjonaChief Medical OfficerSell6,900.0021.76150,144.00138,126.00https://www.sec.gov/Archives/edgar/data/1679082/000120919120050883/0001209191-20-050883-index.htm
2020-08-28Ferreira Juan Camilo ArjonaChief Medical OfficerBuy2,058.007.7816,011.24140,084.00https://www.sec.gov/Archives/edgar/data/1679082/000120919120048799/0001209191-20-048799-index.htm
2020-09-15Ferreira Juan Camilo ArjonaChief Medical OfficerBuy7,000.007.7854,460.00145,026.00https://www.sec.gov/Archives/edgar/data/1679082/000120919120050883/0001209191-20-050883-index.htm
2020-04-03Ferreira Juan Camilo ArjonaChief Medical OfficerBuy87,805.00145,115.00https://www.sec.gov/Archives/edgar/data/1679082/000120919120023793/0001209191-20-023793-index.htm
2020-06-23Ferreira Juan Camilo ArjonaChief Medical OfficerSell4,054.0020.0081,080.00145,115.00https://www.sec.gov/Archives/edgar/data/1679082/000120919120038726/0001209191-20-038726-index.htm
2020-06-24Ferreira Juan Camilo ArjonaChief Medical OfficerSell17,446.0020.00348,920.00145,115.00https://www.sec.gov/Archives/edgar/data/1679082/000120919120039080/0001209191-20-039080-index.htm
2020-08-19Ferreira Juan Camilo ArjonaChief Medical OfficerSell635.0020.0012,700.00145,115.00https://www.sec.gov/Archives/edgar/data/1679082/000120919120047961/0001209191-20-047961-index.htm
2020-08-19Ferreira Juan Camilo ArjonaChief Medical OfficerBuy635.007.784,940.30145,750.00https://www.sec.gov/Archives/edgar/data/1679082/000120919120047961/0001209191-20-047961-index.htm
2020-04-03Matthew LangGeneral Counsel & Corp. Secy.Buy111,268.00145,865.00https://www.sec.gov/Archives/edgar/data/1679082/000120919120023795/0001209191-20-023795-index.htm
2020-08-19Matthew LangGeneral Counsel & Corp. Secy.Sell600.0020.0012,000.00145,865.00https://www.sec.gov/Archives/edgar/data/1679082/000120919120047963/0001209191-20-047963-index.htm
2020-08-26Matthew LangGeneral Counsel & Corp. Secy.Sell100.0020.002,000.00145,865.00https://www.sec.gov/Archives/edgar/data/1679082/000120919120048673/0001209191-20-048673-index.htm
2020-08-28Matthew LangGeneral Counsel & Corp. Secy.Sell2,600.0020.0252,052.00145,865.00https://www.sec.gov/Archives/edgar/data/1679082/000120919120048673/0001209191-20-048673-index.htm
2020-08-31Matthew LangGeneral Counsel & Corp. Secy.Sell26,700.0020.05535,281.60145,865.00https://www.sec.gov/Archives/edgar/data/1679082/000120919120049166/0001209191-20-049166-index.htm
2020-08-26Matthew LangGeneral Counsel & Corp. Secy.Buy100.007.78778.00145,965.00https://www.sec.gov/Archives/edgar/data/1679082/000120919120048673/0001209191-20-048673-index.htm
2020-08-19Matthew LangGeneral Counsel & Corp. Secy.Buy600.007.784,668.00146,465.00https://www.sec.gov/Archives/edgar/data/1679082/000120919120047963/0001209191-20-047963-index.htm
2020-04-03Kim SablichChief Commercial OfficerBuy87,805.00146,710.00https://www.sec.gov/Archives/edgar/data/1679082/000120919120023796/0001209191-20-023796-index.htm
2020-08-28Matthew LangGeneral Counsel & Corp. Secy.Buy2,600.007.7820,228.00148,465.00https://www.sec.gov/Archives/edgar/data/1679082/000120919120048673/0001209191-20-048673-index.htm
2020-06-23Ferreira Juan Camilo ArjonaChief Medical OfficerBuy4,054.007.7831,540.12149,169.00https://www.sec.gov/Archives/edgar/data/1679082/000120919120038726/0001209191-20-038726-index.htm
2020-08-31Ferreira Juan Camilo ArjonaChief Medical OfficerBuy11,307.007.7887,968.46149,333.00https://www.sec.gov/Archives/edgar/data/1679082/000120919120049162/0001209191-20-049162-index.htm
2020-06-24Ferreira Juan Camilo ArjonaChief Medical OfficerBuy10,946.007.7885,159.88156,061.00https://www.sec.gov/Archives/edgar/data/1679082/000120919120039080/0001209191-20-039080-index.htm
2020-06-24Ferreira Juan Camilo ArjonaChief Medical OfficerBuy6,500.007.7850,570.00162,561.00https://www.sec.gov/Archives/edgar/data/1679082/000120919120039080/0001209191-20-039080-index.htm
2020-04-03FRANK KARBEPrincipal Fin'l & AccountingBuy120,146.00163,470.00https://www.sec.gov/Archives/edgar/data/1679082/000120919120023794/0001209191-20-023794-index.htm
2020-08-19FRANK KARBEPrincipal Fin'l & AccountingSell700.0020.0014,000.00163,470.00https://www.sec.gov/Archives/edgar/data/1679082/000120919120047968/0001209191-20-047968-index.htm
2020-08-28FRANK KARBEPrincipal Fin'l & AccountingSell3,650.0020.0473,146.00163,470.00https://www.sec.gov/Archives/edgar/data/1679082/000120919120048927/0001209191-20-048927-index.htm
2020-08-31FRANK KARBEPrincipal Fin'l & AccountingSell21,150.0020.01423,274.95163,470.00https://www.sec.gov/Archives/edgar/data/1679082/000120919120048927/0001209191-20-048927-index.htm
2020-09-15FRANK KARBEPrincipal Fin'l & AccountingSell750.0021.7316,297.50163,470.00https://www.sec.gov/Archives/edgar/data/1679082/000120919120050887/0001209191-20-050887-index.htm
2020-08-19FRANK KARBEPrincipal Fin'l & AccountingBuy700.005.113,577.00164,170.00https://www.sec.gov/Archives/edgar/data/1679082/000120919120047968/0001209191-20-047968-index.htm
2020-09-15FRANK KARBEPrincipal Fin'l & AccountingBuy750.005.113,832.50164,220.00https://www.sec.gov/Archives/edgar/data/1679082/000120919120050887/0001209191-20-050887-index.htm
2020-08-28FRANK KARBEPrincipal Fin'l & AccountingBuy3,650.005.1118,651.50167,120.00https://www.sec.gov/Archives/edgar/data/1679082/000120919120048927/0001209191-20-048927-index.htm
2020-08-31Matthew LangGeneral Counsel & Corp. Secy.Buy26,700.007.78207,726.00172,565.00https://www.sec.gov/Archives/edgar/data/1679082/000120919120049166/0001209191-20-049166-index.htm
2020-08-31FRANK KARBEPrincipal Fin'l & AccountingBuy21,150.005.11108,076.50184,620.00https://www.sec.gov/Archives/edgar/data/1679082/000120919120048927/0001209191-20-048927-index.htm
2019-06-12Kathleen SebeliusDirectorBuy100.008.93893.00200.00https://www.sec.gov/Archives/edgar/data/1679082/000120919119037137/0001209191-19-037137-index.htm
2018-12-17Kim SablichChief Commercial OfficerBuy29,700.0029,700.00https://www.sec.gov/Archives/edgar/data/1679082/000120919118063255/0001209191-18-063255-index.htm
2019-12-30Matthew LangGeneral Counsel & Corp. Secy.Sell19,018.0015.55295,729.9034,597.00https://www.sec.gov/Archives/edgar/data/1679082/000120919119062189/0001209191-19-062189-index.htm
2019-06-04Andrew Lo10% Share HolderBuy2,424,242.008.2519,999,996.5040,765,599.00https://www.sec.gov/Archives/edgar/data/1679082/000091957419003993/0000919574-19-003993-index.htm
2019-06-04GLOBAL INVESTORS LP VIKING10% Share HolderBuy2,424,242.008.2519,999,996.5040,765,599.00https://www.sec.gov/Archives/edgar/data/1679082/000090342319000245/0000903423-19-000245-index.htm
2019-06-04Holdings Ltd. Dexxon10% Share HolderBuy2,424,242.008.2519,999,996.5040,765,599.00https://www.sec.gov/Archives/edgar/data/1679082/000114420419030140/0001144204-19-030140-index.htm
2019-06-04Investments (UK) Ltd SVF10% Share HolderBuy2,424,242.008.2519,999,996.5040,765,599.00https://www.sec.gov/Archives/edgar/data/1679082/000120919119035256/0001209191-19-035256-index.htm
2019-06-04Patrick Machado10% Share HolderBuy2,424,242.008.2519,999,996.5040,765,599.00https://www.sec.gov/Archives/edgar/data/1679082/000110465919034355/0001104659-19-034355-index.htm
2019-06-04QVT Associates GP LLC10% Share HolderBuy2,424,242.008.2519,999,996.5040,765,599.00https://www.sec.gov/Archives/edgar/data/1679082/000089924319015895/0000899243-19-015895-index.htm
2019-06-04Sciences Ltd. Roivant10% Share HolderBuy2,424,242.008.2519,999,996.5040,765,599.00https://www.sec.gov/Archives/edgar/data/1679082/000110465919034348/0001104659-19-034348-index.htm
2019-06-04VIKING GLOBAL PERFORMANCE LLC10% Share HolderBuy2,424,242.008.2519,999,996.5040,765,599.00https://www.sec.gov/Archives/edgar/data/1679082/000090342319000244/0000903423-19-000244-index.htm
2019-11-20Sciences Ltd. Roivant10% Share HolderBuy121,906.0012.901,572,587.4040,887,505.00https://www.sec.gov/Archives/edgar/data/1679082/000110465919066768/0001104659-19-066768-index.htm
2019-11-21Sciences Ltd. Roivant10% Share HolderBuy103,613.0011.801,222,633.4040,991,118.00https://www.sec.gov/Archives/edgar/data/1679082/000110465919066768/0001104659-19-066768-index.htm
2019-11-21Sciences Ltd. Roivant10% Share HolderBuy18,293.0012.38226,467.3441,009,411.00https://www.sec.gov/Archives/edgar/data/1679082/000110465919066768/0001104659-19-066768-index.htm
2019-12-30FRANK KARBEPrincipal Fin'l & AccountingSell19,701.0015.55306,350.5543,324.00https://www.sec.gov/Archives/edgar/data/1679082/000120919119062187/0001209191-19-062187-index.htm
2019-11-25Sciences Ltd. Roivant10% Share HolderBuy3,500,000.0015.0052,500,000.0044,509,411.00https://www.sec.gov/Archives/edgar/data/1679082/000110465919068249/0001104659-19-068249-index.htm
2019-12-02Sciences Ltd. Roivant10% Share HolderBuy113,668.0018.212,069,894.2844,623,079.00https://www.sec.gov/Archives/edgar/data/1679082/000110465919069974/0001104659-19-069974-index.htm
2019-12-02Sciences Ltd. Roivant10% Share HolderBuy65,525.0018.851,235,146.2544,688,604.00https://www.sec.gov/Archives/edgar/data/1679082/000110465919069974/0001104659-19-069974-index.htm
2019-12-04Sciences Ltd. Roivant10% Share HolderBuy72,471.0017.041,234,905.8444,761,075.00https://www.sec.gov/Archives/edgar/data/1679082/000110465919069974/0001104659-19-069974-index.htm
2019-12-04Sciences Ltd. Roivant10% Share HolderBuy2,529.0017.5644,409.2444,763,604.00https://www.sec.gov/Archives/edgar/data/1679082/000110465919069974/0001104659-19-069974-index.htm
2019-12-16Sciences Ltd. Roivant10% Share HolderBuy131,541.0014.971,969,168.7744,895,145.00https://www.sec.gov/Archives/edgar/data/1679082/000110465919073807/0001104659-19-073807-index.htm
2019-12-16Sciences Ltd. Roivant10% Share HolderBuy38,459.0015.68603,037.1244,933,604.00https://www.sec.gov/Archives/edgar/data/1679082/000110465919073807/0001104659-19-073807-index.htm
2019-12-17Sciences Ltd. Roivant10% Share HolderBuy75,000.0015.941,195,500.0045,008,604.00https://www.sec.gov/Archives/edgar/data/1679082/000110465919073807/0001104659-19-073807-index.htm
2020-03-16Sumitomo Chemical Co., Ltd.10% Share HolderBuy193,900.007.251,406,007.6845,202,504.00https://www.sec.gov/Archives/edgar/data/1679082/000089924320008835/0000899243-20-008835-index.htm
2020-03-17Sumitomo Chemical Co., Ltd.10% Share HolderBuy193,900.007.401,433,948.6745,396,404.00https://www.sec.gov/Archives/edgar/data/1679082/000089924320008835/0000899243-20-008835-index.htm
2020-03-18Sumitomo Chemical Co., Ltd.10% Share HolderBuy193,900.007.401,434,937.5645,590,304.00https://www.sec.gov/Archives/edgar/data/1679082/000089924320009088/0000899243-20-009088-index.htm
2020-03-19Sumitomo Chemical Co., Ltd.10% Share HolderBuy193,900.007.681,488,958.1045,784,204.00https://www.sec.gov/Archives/edgar/data/1679082/000089924320009088/0000899243-20-009088-index.htm
2020-03-20Sumitomo Chemical Co., Ltd.10% Share HolderBuy193,900.007.601,472,709.2845,978,104.00https://www.sec.gov/Archives/edgar/data/1679082/000089924320009332/0000899243-20-009332-index.htm
2020-03-23Sumitomo Chemical Co., Ltd.10% Share HolderBuy211,200.007.681,621,931.5246,189,304.00https://www.sec.gov/Archives/edgar/data/1679082/000089924320009332/0000899243-20-009332-index.htm
2020-03-24Sumitomo Chemical Co., Ltd.10% Share HolderBuy211,200.007.671,620,558.7246,400,504.00https://www.sec.gov/Archives/edgar/data/1679082/000089924320009469/0000899243-20-009469-index.htm
2020-03-25Sumitomo Chemical Co., Ltd.10% Share HolderBuy108,100.007.60821,895.1146,508,604.00https://www.sec.gov/Archives/edgar/data/1679082/000089924320009469/0000899243-20-009469-index.htm
2020-03-26Sumitomo Chemical Co., Ltd.10% Share HolderBuy70,000.007.94555,807.0046,578,604.00https://www.sec.gov/Archives/edgar/data/1679082/000089924320009633/0000899243-20-009633-index.htm
2020-03-27Sumitomo Chemical Co., Ltd.10% Share HolderBuy70,000.007.98558,250.0046,648,604.00https://www.sec.gov/Archives/edgar/data/1679082/000089924320009633/0000899243-20-009633-index.htm
2020-03-30Sumitomo Chemical Co., Ltd.10% Share HolderBuy70,000.007.65535,766.0046,718,604.00https://www.sec.gov/Archives/edgar/data/1679082/000089924320009776/0000899243-20-009776-index.htm
2020-03-31Sumitomo Chemical Co., Ltd.10% Share HolderBuy70,000.007.97557,984.0046,788,604.00https://www.sec.gov/Archives/edgar/data/1679082/000089924320009776/0000899243-20-009776-index.htm
2020-04-01Sumitomo Chemical Co., Ltd.10% Share HolderBuy70,000.007.46522,298.0046,858,604.00https://www.sec.gov/Archives/edgar/data/1679082/000089924320010095/0000899243-20-010095-index.htm
2020-04-02Sumitomo Chemical Co., Ltd.10% Share HolderBuy70,000.007.73541,086.0046,928,604.00https://www.sec.gov/Archives/edgar/data/1679082/000089924320010095/0000899243-20-010095-index.htm
2020-04-03Sumitomo Chemical Co., Ltd.10% Share HolderBuy70,000.007.93554,925.0046,998,604.00https://www.sec.gov/Archives/edgar/data/1679082/000089924320010382/0000899243-20-010382-index.htm
2020-04-06Sumitomo Chemical Co., Ltd.10% Share HolderBuy70,000.008.44590,520.0047,068,604.00https://www.sec.gov/Archives/edgar/data/1679082/000089924320010382/0000899243-20-010382-index.htm
2020-04-07Sumitomo Chemical Co., Ltd.10% Share HolderBuy70,000.008.21574,364.0047,138,604.00https://www.sec.gov/Archives/edgar/data/1679082/000089924320010563/0000899243-20-010563-index.htm
2020-04-08Sumitomo Chemical Co., Ltd.10% Share HolderBuy70,000.008.53596,939.0047,208,604.00https://www.sec.gov/Archives/edgar/data/1679082/000089924320010563/0000899243-20-010563-index.htm
2020-04-09Sumitomo Chemical Co., Ltd.10% Share HolderBuy70,000.009.37655,669.0047,278,604.00https://www.sec.gov/Archives/edgar/data/1679082/000089924320010666/0000899243-20-010666-index.htm
2020-04-13Sumitomo Chemical Co., Ltd.10% Share HolderBuy70,000.009.81686,546.0047,348,604.00https://www.sec.gov/Archives/edgar/data/1679082/000089924320010804/0000899243-20-010804-index.htm
2020-04-14Sumitomo Chemical Co., Ltd.10% Share HolderBuy70,000.0011.00770,105.0047,418,604.00https://www.sec.gov/Archives/edgar/data/1679082/000089924320010804/0000899243-20-010804-index.htm
2020-04-15Sumitomo Chemical Co., Ltd.10% Share HolderBuy70,000.0010.48733,698.0047,488,604.00https://www.sec.gov/Archives/edgar/data/1679082/000089924320010899/0000899243-20-010899-index.htm
2020-04-16Sumitomo Chemical Co., Ltd.10% Share HolderBuy70,000.0010.64744,674.0047,558,604.00https://www.sec.gov/Archives/edgar/data/1679082/000089924320010899/0000899243-20-010899-index.htm
2020-04-17Sumitomo Chemical Co., Ltd.10% Share HolderBuy70,000.0010.76753,536.0047,628,604.00https://www.sec.gov/Archives/edgar/data/1679082/000089924320011041/0000899243-20-011041-index.htm
2020-04-20Sumitomo Chemical Co., Ltd.10% Share HolderBuy50,300.0011.82594,425.2847,678,904.00https://www.sec.gov/Archives/edgar/data/1679082/000089924320011041/0000899243-20-011041-index.htm
2020-04-21Sumitomo Chemical Co., Ltd.10% Share HolderBuy50,200.0011.58581,140.3047,729,104.00https://www.sec.gov/Archives/edgar/data/1679082/000089924320011209/0000899243-20-011209-index.htm
2020-04-22Sumitomo Chemical Co., Ltd.10% Share HolderBuy50,000.0011.93596,730.0047,779,104.00https://www.sec.gov/Archives/edgar/data/1679082/000089924320011209/0000899243-20-011209-index.htm
2020-04-23Sumitomo Chemical Co., Ltd.10% Share HolderBuy35,000.0012.35432,103.0047,814,104.00https://www.sec.gov/Archives/edgar/data/1679082/000089924320011334/0000899243-20-011334-index.htm
2020-04-24Sumitomo Chemical Co., Ltd.10% Share HolderBuy43,086.0012.15523,344.1047,857,190.00https://www.sec.gov/Archives/edgar/data/1679082/000089924320011334/0000899243-20-011334-index.htm
2020-04-27Sumitomo Chemical Co., Ltd.10% Share HolderBuy40,503.0012.18493,302.2447,897,693.00https://www.sec.gov/Archives/edgar/data/1679082/000089924320011506/0000899243-20-011506-index.htm
2020-04-28Sumitomo Chemical Co., Ltd.10% Share HolderBuy50,000.0012.05602,720.0047,947,693.00https://www.sec.gov/Archives/edgar/data/1679082/000089924320011506/0000899243-20-011506-index.htm
2020-04-29Sumitomo Chemical Co., Ltd.10% Share HolderBuy50,000.0011.92595,895.0047,997,693.00https://www.sec.gov/Archives/edgar/data/1679082/000089924320011728/0000899243-20-011728-index.htm
2020-04-30Sumitomo Chemical Co., Ltd.10% Share HolderBuy50,000.0012.08603,825.0048,047,693.00https://www.sec.gov/Archives/edgar/data/1679082/000089924320011728/0000899243-20-011728-index.htm
2020-05-01Sumitomo Chemical Co., Ltd.10% Share HolderBuy50,000.0011.38569,180.0048,097,693.00https://www.sec.gov/Archives/edgar/data/1679082/000089924320012040/0000899243-20-012040-index.htm
2020-05-04Sumitomo Chemical Co., Ltd.10% Share HolderBuy50,000.0011.50574,870.0048,147,693.00https://www.sec.gov/Archives/edgar/data/1679082/000089924320012040/0000899243-20-012040-index.htm
2020-05-05Sumitomo Chemical Co., Ltd.10% Share HolderBuy50,000.0011.69584,465.0048,197,693.00https://www.sec.gov/Archives/edgar/data/1679082/000089924320012209/0000899243-20-012209-index.htm
2020-05-05Sumitomo Chemical Co., Ltd.10% Share HolderBuy50,000.0012.24612,075.0048,247,693.00https://www.sec.gov/Archives/edgar/data/1679082/000089924320012209/0000899243-20-012209-index.htm
2020-05-07Sumitomo Chemical Co., Ltd.10% Share HolderBuy35,000.0012.63442,137.5048,282,693.00https://www.sec.gov/Archives/edgar/data/1679082/000089924320012570/0000899243-20-012570-index.htm
2020-05-08Sumitomo Chemical Co., Ltd.10% Share HolderBuy35,000.0012.83449,074.5048,317,693.00https://www.sec.gov/Archives/edgar/data/1679082/000089924320012570/0000899243-20-012570-index.htm
2020-05-11Sumitomo Chemical Co., Ltd.10% Share HolderBuy35,000.0012.78447,384.0048,352,693.00https://www.sec.gov/Archives/edgar/data/1679082/000089924320013027/0000899243-20-013027-index.htm
2020-05-12Sumitomo Chemical Co., Ltd.10% Share HolderBuy24,448.0013.51330,404.9448,377,141.00https://www.sec.gov/Archives/edgar/data/1679082/000089924320013027/0000899243-20-013027-index.htm
2020-05-13Sumitomo Chemical Co., Ltd.10% Share HolderBuy41,331.0012.38511,640.5848,418,472.00https://www.sec.gov/Archives/edgar/data/1679082/000089924320013205/0000899243-20-013205-index.htm
2020-05-14Sumitomo Chemical Co., Ltd.10% Share HolderBuy50,000.0012.02600,760.0048,468,472.00https://www.sec.gov/Archives/edgar/data/1679082/000089924320013205/0000899243-20-013205-index.htm
2020-05-15Sumitomo Chemical Co., Ltd.10% Share HolderBuy49,812.0012.12603,965.5248,518,284.00https://www.sec.gov/Archives/edgar/data/1679082/000089924320013546/0000899243-20-013546-index.htm
2020-05-18Sumitomo Chemical Co., Ltd.10% Share HolderBuy35,000.0012.36432,624.5048,553,284.00https://www.sec.gov/Archives/edgar/data/1679082/000089924320013546/0000899243-20-013546-index.htm
2020-05-19Sumitomo Chemical Co., Ltd.10% Share HolderBuy50,000.0012.10605,050.0048,603,284.00https://www.sec.gov/Archives/edgar/data/1679082/000089924320013825/0000899243-20-013825-index.htm
2020-05-20Sumitomo Chemical Co., Ltd.10% Share HolderBuy37,897.0012.58476,861.7448,641,181.00https://www.sec.gov/Archives/edgar/data/1679082/000089924320013825/0000899243-20-013825-index.htm
2019-06-12Kathleen SebeliusDirectorBuy300.008.922,676.00500.00https://www.sec.gov/Archives/edgar/data/1679082/000120919119037137/0001209191-19-037137-index.htm
2019-06-12Kathleen SebeliusDirectorBuy4,500.008.9640,320.005,000.00https://www.sec.gov/Archives/edgar/data/1679082/000120919119037137/0001209191-19-037137-index.htm
2019-08-26Matthew LangGeneral Counsel & Corp. Secy.Buy53,615.0053,615.00https://www.sec.gov/Archives/edgar/data/1679082/000120919119047546/0001209191-19-047546-index.htm
2019-08-26Ferreira Juan Camilo ArjonaChief Medical OfficerBuy47,570.0057,310.00https://www.sec.gov/Archives/edgar/data/1679082/000120919119047541/0001209191-19-047541-index.htm
2020-03-18Kim SablichChief Commercial OfficerSell15.006.93103.9558,905.00https://www.sec.gov/Archives/edgar/data/1679082/000120919120020279/0001209191-20-020279-index.htm
2020-03-18Kim SablichChief Commercial OfficerSell770.007.385,682.6058,920.00https://www.sec.gov/Archives/edgar/data/1679082/000120919120020279/0001209191-20-020279-index.htm
2020-01-15Kim SablichChief Commercial OfficerSell4,840.0014.0467,953.6059,690.00https://www.sec.gov/Archives/edgar/data/1679082/000120919120003741/0001209191-20-003741-index.htm
2019-08-26FRANK KARBEPrincipal Fin'l & AccountingBuy55,025.0063,025.00https://www.sec.gov/Archives/edgar/data/1679082/000120919119047542/0001209191-19-047542-index.htm
2019-12-18Kim SablichChief Commercial OfficerSell2,585.0016.2241,928.7064,530.00https://www.sec.gov/Archives/edgar/data/1679082/000120919119061300/0001209191-19-061300-index.htm
2019-08-26Kim SablichChief Commercial OfficerBuy37,415.0067,115.00https://www.sec.gov/Archives/edgar/data/1679082/000120919119047548/0001209191-19-047548-index.htm
2019-06-11FRANK KARBEPrincipal Fin'l & AccountingBuy8,000.009.1072,800.008,000.00https://www.sec.gov/Archives/edgar/data/1679082/000120919119036115/0001209191-19-036115-index.htm
2019-02-15Ferreira Juan Camilo ArjonaChief Medical OfficerSell260.0021.155,499.009,740.00https://www.sec.gov/Archives/edgar/data/1679082/000120919119011541/0001209191-19-011541-index.htm